Results 91 to 100 of about 5,721 (196)

ePosters Virtual

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome

open access: yesКардиоваскулярная терапия и профилактика, 2006
Aim. To assess nebivolol clinical effects on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. In total, 21 patients were administered nebivolol (5 mg/d) for one month. Dynamics
I. N. Medvedev
doaj  

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure

open access: yes, 2010
Donatella Del Sindaco1, Maria Denitza Tinti2, Luca Monzo2, Giovanni Pulignano2,1Heart Failure Unit, Division of Cardiology, INRCA Institute of Care and Research for Elderly, Rome, Italy; 2Heart Failure Clinic, Division of Cardiology/CCU, San Camillo ...
MONZO, LUCA   +10 more
core   +1 more source

PLEIOTROPIC EFFECT OF NEBIVOLOL: RECENT DATA

open access: yes, 2015
The article focuses on the review of recent data on Nebivolol as hypotensive and cardioprotecting medication. The accent is set upon the specific properties of nebivolol, partly, its influence on nitric oxide metabolism.
O. Yu. Shaydyuk, E. O. Taratukhin
core   +1 more source

Role of nebivolol in anthracycline-induced cardiotoxicity

open access: yes, 2019
Background: Anthracyclines are extensively used in the treatment of breast cancer. However, these therapeutic agents are responsible for chemotherapy-induced cardiotoxicity.
Govind, Biju   +2 more
core   +1 more source

Protective Role of Nebivolol in Hydroxyl Radical Induced Injury

open access: yes, 2001
Increased oxidative stress has been postulated as one of the main mechanisms underlying stunned myocardium, and may play an important role in and during development of heart failure.
Paul M. L. Janssen   +7 more
core   +1 more source

Nebivolol: An endothelium-friendly selective β 1- adrenoceptor blocker

open access: yes, 2012
Nebivolol is a highly selective β 1-adrenoceptor blocker, which also stimulates endothelial nitric oxide synthase and scavenges reactive oxygen species (ROS).
Gao, Yuansheng   +5 more
core   +1 more source

Comparison of antiproliferative effects of amlodipine and nebivolol against MCF-7 cells: An in vitro study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology
Background: Breast cancer (BC) has become the most common cancer among women in India. Both amlodipine, belonging to calcium channel blockers, and nebivolol, belonging to the beta blockers class have proven anticancer mechanisms.
Hemalatha A   +4 more
doaj   +1 more source

Nebivolol and airway responsiveness in the rabbit.

open access: yes, 2001
Beta-adrenergic receptor antagonists are currently used as first-line therapy in the treatment of hypertension and angina pectoris, but are contraindicated or used with caution in patients with bronchospastic syndromes. In this study we evaluated in vivo
M. Mangrella   +13 more
core   +1 more source

Nebivolol: quantum-chemical properties

open access: yes, 2015
Дослiджено квантово-хiмiчнi властивостi молекули β-адреноблокатора небiвололу. Рiзноманiтнiсть функцiональних груп молекули небiвололу свiдчить про можливiсть її взаємодiяти з полярними та з неполярними структурами бiомембран.
Загородний, М.І.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy